As seen on:

Glass Pharms news

All
  • All
  • Carbon Negative
  • Education
  • Medical Cannabis
  • Milestones
  • Pharmaceutical Innovation
  • Protected Horticulture
  • Uncategorized

Adam George joins Glass Pharms as Chairman

Adam George joins as Chairman Glass Pharms, the UK-based medical cannabis cultivation company, is delighted to announce the appointment of Adam George as Chairman. Adam officially joined the board on 1st December 2024.Glass Pharms chief executive, James Duckenfield said “We are delighted that Adam has joined the board. He brings unparalleled experience in pharmaceutical cannabis, with over 13 years spent at GW Pharmaceuticals including positions of CFO and UK managing director. He will support us in our mission to bring high quality pharmaceutical cannabis products to UK patients”Adam left GW Pharmaceuticals, now Jazz Pharmaceuticals, in 2020 and has other interests in businesses developing medicines derived from or inspired by plants, fungi and other natural sources.Adam George said, “It’s an exciting time to join Glass Pharms. With solid foundations laid through a world-class cultivation facility and an excellent team, the business is well-positioned to capitalise on the growing demand for high quality,...
Continue Reading about How Glass Pharms® grows medical cannabis off-grid, powered by food waste about End of Batch Growing about End of Batch Growing about End of Batch Growing about End of Batch Growing about End of Batch Growing about End of Batch Growing about Adam George joins Glass Pharms as Chairman

CBPMs could save NHS £4B

Allowing CBPMs to be prescribed on the NHS for chronic pain could save the NHS almost £4B per annum, according to a study by York University, part-funded by Glass Pharms. We hope that NICE will review their study from 2019 which used assumptions of medicine cost which are not consistent with the current market.James Duckenfield, CEO of Glass Pharms, “Despite medicinal cannabis being legalised in 2018, there are still only a few NHS patients receiving unlicensed cannabis-derived medicines. We hope that NICE will review the evidence from this Health Economic Analysis and adapt its guidance accordingly. Now is the time to expand the NHS offering to allow unlicensed cannabis medicines to be prescribed for chronic pain.” 
Continue Reading about How Glass Pharms® grows medical cannabis off-grid, powered by food waste about End of Batch Growing about End of Batch Growing about End of Batch Growing about End of Batch Growing about End of Batch Growing about End of Batch Growing about CBPMs could save NHS £4B

Releaf + Glass Pharms

Releaf + Glass Pharms agree landmark dealReleaf and Glass Pharms have agreed on a landmark multi-million pound deal that will see it grow 145kg of cannabis flower per month to supply CBPMs for Releaf's patients.Glass Pharms' continuous manufacturing facility will support the rapid growth of Releaf's clinic, believed to be the fastest growing in the UK.
Continue Reading about How Glass Pharms® grows medical cannabis off-grid, powered by food waste about End of Batch Growing about End of Batch Growing about End of Batch Growing about End of Batch Growing about End of Batch Growing about End of Batch Growing about Releaf + Glass Pharms

R&D Collaboration with James Hutton Institute

Olivier Dehon (CFO, Glass Pharms), Prof. Derek Stewart (James Hutton Institute), Richard Lewis (MD, Glass Pharms), Dr Raul Huertas (James Hutton Institute)Glass Pharms and the Advanced Plant Growth Centre at The James Hutton Institute are to conduct a medical cannabis research program, funded by UKRI's Biotechnology and Biological Sciences Research Council (BBSRC). Pictured from left: Olivier Dehon (CFO, Glass Pharms), Prof. Derek Stewart (James Hutton Institute), Richard Lewis (MD, Glass Pharms), Dr Raul Huertas (James Hutton Institute).
Continue Reading about How Glass Pharms® grows medical cannabis off-grid, powered by food waste about End of Batch Growing about End of Batch Growing about End of Batch Growing about End of Batch Growing about End of Batch Growing about End of Batch Growing about R&D Collaboration with James Hutton Institute

Wiltshire Police Education Day

Wiltshire Police Education Day 19/08/2024 We were delighted to welcome the drug expert team from Wiltshire Police for an education day onsite at Glass Pharms. This was part of our ongoing process of mutual education and collaboration with law enforcement.
Continue Reading about How Glass Pharms® grows medical cannabis off-grid, powered by food waste about End of Batch Growing about End of Batch Growing about End of Batch Growing about End of Batch Growing about End of Batch Growing about End of Batch Growing about Wiltshire Police Education Day

Devon & Cornwall Police Education Day

Devon & Cornwall Police Education Day 27/06/2024We were delighted to welcome the Drug Expert and Drugs Focus Desk teams from Devon & Cornwall Police for an education day onsite. Thanks to them for their time. Our view is that working closely with law enforcement is the best way to foster mutual understanding and create the right environment for legitimate Medical Cannabis.
Continue Reading about How Glass Pharms® grows medical cannabis off-grid, powered by food waste about End of Batch Growing about End of Batch Growing about End of Batch Growing about End of Batch Growing about End of Batch Growing about End of Batch Growing about Devon & Cornwall Police Education Day

Drone Helps Climate Control

Drone footage - click on image  We aim to have the same climate in our greenhouse throughout the year. That means that in the summer we actually get too much light which turns into heat - yes, even in the UK! Heat stress can lead to hermaphrodism in cannabis. This in turn leads to fertilisation of flowers which generate seeds. Seeds are not permitted in medical cannabis in the UK. We use an AI controlled drone to apply a diffusion coating to our glass roof. The diffused light doesn't cast shadows that would create uneven light for the plants. Diffusion allows our climate computer to use shading algorithms as part of our climate control strategy and a small part of the reason we guarantee no seeds in our product. cannabis seeds agricultural drone
Continue Reading about How Glass Pharms® grows medical cannabis off-grid, powered by food waste about End of Batch Growing about End of Batch Growing about End of Batch Growing about End of Batch Growing about End of Batch Growing about End of Batch Growing about Drone Helps Climate Control

In Conversation with Rt Hon. Wes Streeting MP

In conversation with Wes Streeting  Our CEO, James Duckenfield, attended an event at The Royal Society of Medicine where Rt. Hon. Wes Streeting MP spoke with passion about the NHS and his personal battle with kidney cancer. Of note was his desire to work with the Life Sciences industry and make the UK a destination for life sciences and manufacturing. He would like to see public services treat those who it serves as customers and allow patients to self-refer to specialists.
Continue Reading about How Glass Pharms® grows medical cannabis off-grid, powered by food waste about End of Batch Growing about End of Batch Growing about End of Batch Growing about End of Batch Growing about End of Batch Growing about End of Batch Growing about In Conversation with Rt Hon. Wes Streeting MP